NCT06729073View on ClinicalTrials.gov

Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

June 10, 2025

Study Completion Date

July 31, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

Diclofenac sodium gel

topical administration

DRUG

Diclofenac diethylamine 1.16% gel

Topical administration

Trial Locations (1)

Unknown

Nuvisan, Neu-Ulm

Sponsors

Lead Sponsor

Amzell
All Listed Sponsors
lead

Amzell

INDUSTRY

NCT06729073 - Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days. | Biotech Hunter | Biotech Hunter